preclinical cancer research

KUBTEC Scientific’s XCELL TomoRad targets a major bottleneck in preclinical radiotherapy studies

Medical Devices & Diagnostics

Can KUBTEC Scientific lower the barrier to image-guided radiotherapy in cancer research?

by Pallavi Madhiraju
May 9, 2026
0 Comments

Preclinical IGRT is powerful but costly. KUBTEC Scientific’s XCELL TomoRad tests whether access, speed, and targeting can finally align.

Read More

Representative image of preclinical oncology research linked to Soley Therapeutics’ STX-6398 program, highlighting the growing interest in CKAP2-targeted cancer drug discovery after AACR 2026.

Pharma & Biotech

Soley Therapeutics shows early tumor selectivity for STX-6398, but can CKAP2 modulation scale?

by Pallavi Madhiraju
April 18, 2026
0 Comments

Soley Therapeutics unveiled AACR 2026 data for STX-6398. Read why CKAP2 modulation could open a new path in oncology.

Read More